Treatments & Interventions
Cortisone
substance
Hydrocortisone butyrate
substance
Hydrocortisone valerate
substance
Psyllium
substance
Azathioprine sodium
substance
Nicotine
substance
Nicotine polacrilex
substance
Hydrocortisone acetate
substance
Methylprednisolone acetate
substance
Prednisolone acetate
substance
Prednisolone sodium phosphate
substance
Prednisolone tertiary butylacetate
substance
Olsalazine sodium
substance
Hydrocortisone cypionate
substance
Hydrocortisone sodium phosphate
substance
Hydrocortisone sodium succinate
substance
Dexamethasone acetate
substance
Methylprednisolone
substance
Triamcinolone
substance
Triamcinolone diacetate
substance
Clinical Trials
Recent Trials
Immune Regulation in Ulcerative Colitis or Crohn s Disease
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 64766004
- UMLS CUI
- C0009324
- Fully Specified Name
- Ulcerative colitis (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 11
- Known Treatments
- 20
- Clinical Trials
- 84
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.